-+ 0.00%
-+ 0.00%
-+ 0.00%

Craig-Hallum Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $35

Benzinga·03/20/2026 17:15:57
Listen to the news
Craig-Hallum analyst Chase Knickerbocker maintains Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and raises the price target from $30 to $35.